Benzothiazinone analogs as Anti-Mycobacterium tuberculosis DprE1 irreversible inhibitors: Covalent docking, validation, and molecular dynamics simulations
Fig 11
Estimated physiochemical features of PubChem-155-924-621, PubChem-127-032-794, PubChem-155-923-972, and PBTZ169 as DprE1 inhibitors.